Hillsdale Investment Management’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,620
Closed -$546K 598
2022
Q2
$546K Buy
5,620
+100
+2% +$10.2K 0.04% 314
2022
Q1
$620K Buy
+5,520
New +$588K 0.04% 330
2021
Q2
Sell
-13,148
Closed -$1.68M 635
2021
Q1
$1.68M Hold
13,148
0.14% 164
2020
Q4
$2.36M Sell
13,148
-3,652
-22% -$812K 0.22% 137
2020
Q3
$3.69M Sell
16,800
-1,000
-6% -$223K 0.36% 74
2020
Q2
$3.98M Buy
17,800
+10,100
+131% +$1.58M 0.36% 69
2020
Q1
$753K Buy
+7,700
New +$623K 0.09% 185

Other funds holding QDEL

Hillsdale Investment Management's QDEL Position: Q3 2022 in Review

Hillsdale Investment Management sold out of QuidelOrtho (QDEL) in Q3 2022, closing a stake of 5,620 shares — an estimated $546K sold.

Hillsdale Investment Management first reported a position in QDEL in Q1 2020 and held it in 7 quarters. The position peaked at $3.98M in Q2 2020. 315 funds tracked by Wall St. Rank hold QDEL as of Q3 2022.

  • Hillsdale Investment Management reported no remaining QuidelOrtho position as of Q3 2022 after selling out during the quarter.
  • Hillsdale Investment Management sold 5,620 QuidelOrtho shares in Q3 2022, an estimated $546K.
  • Hillsdale Investment Management first reported a position in QuidelOrtho in Q1 2020 and held it in 7 quarters.
  • Hillsdale Investment Management's QuidelOrtho position peaked at $3.98M in Q2 2020.
  • 315 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2022.

Based on Hillsdale Investment Management's 13F filing for Q3 2022, filed 10 Nov 2022.